You are here

  • Home
  • Archive
  • Volume 69, Issue 12
  • Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry

Article metrics

Article menu

Download PDFPDF

Short report
Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry

 

Online download statistics by month:

Online download statistics by month: October 2016 to March 2024

AbstractFullPdf
Oct 201636416651
Nov 201644010037
Dec 20162446332
Jan 20171615435
Feb 2017282919
Mar 201745921
Apr 201724313
May 20174398
Jun 201710289
Jul 201735338
Aug 201738317
Sep 201758463
Oct 201749416
Nov 201711310712
Dec 201758587
Jan 201860565
Feb 201821174
Mar 20181541463
Apr 201863595
May 20181181022
Jun 201867530
Jul 2018705810
Aug 20181321203
Sep 2018115892
Oct 20181241117
Nov 20181351112
Dec 20181301122
Jan 201989856
Feb 201992612
Mar 201973336
Apr 2019291110
May 201929126
Jun 201921919
Jul 2019181255
Aug 2019272011
Sep 201914129
Oct 201914115
Nov 20191295
Dec 201923139
Jan 202010109
Feb 202013125
Mar 202035299
Apr 202010710
May 2020211812
Jun 2020131220
Jul 2020141435
Aug 202011918
Sep 2020994
Oct 20201495
Nov 202012129
Dec 2020111113
Jan 2021171011
Feb 202130135
Mar 202118119
Apr 202131165
May 202121146
Jun 202124173
Jul 202121204
Aug 2021161314
Sep 2021777
Oct 2021161219
Nov 2021201111
Dec 202115133
Jan 202220166
Feb 202224162
Mar 202214137
Apr 202215147
May 202239337
Jun 202231235
Jul 202220123
Aug 202231294
Sep 2022322524
Oct 202251439
Nov 202215136
Dec 20221095
Jan 2023885
Feb 202329293
Mar 202310103
Apr 2023542
May 2023999
Jun 20231072
Jul 20236514
Aug 2023666
Sep 2023870
Oct 2023773
Nov 202313138
Dec 202317135
Jan 202416161
Feb 202411113
Mar 20241073
Total41142926854